We are live on ! Find out more
SC

Sessa Capital Portfolio holdings

AUM $5.51B
1-Year Est. Return 47.23%
This Fund
S&P 500
This Quarter Est. Return
+20.83%
1 Year Est. Return
+47.23%
3 Year Est. Return
+78.73%
5 Year Est. Return
+129.49%
10 Year Est. Return
+553.63%
AUM
$2.64B
AUM Growth
+$1.01B
Cap. Flow
+$751M
Cap. Flow %
28.51%
Top 10 Hldgs %
70.98%
Holding
49
New
17
Increased
3
Reduced
4
Closed
11

Top Buys

Rank Stock Value
1
ALLY icon
Ally Financial
ALLY
+$220M
2
FCNCA icon
First Citizens BancShares
FCNCA
+$121M
3
GEHC icon
GE HealthCare
GEHC
+$104M
4
AIG icon
American International
AIG
+$84.7M
5
TGNA
TEGNA Inc
TGNA
+$67.7M

Top Sells

Rank Stock Value
1
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$75.3M
2
META icon
Meta Platforms (Facebook)
META
+$48.1M
3
NWSA icon
News Corp Class A
NWSA
+$42.1M
4
WBD icon
Warner Bros
WBD
+$23.1M
5
NWS icon
News Corp Class B
NWS
+$20.8M

Sector Composition

Rank Sector Weight
1 Financials 28.84%
2 Communication Services 21.8%
3 Healthcare 16.71%
4 Materials 5.64%
5 Technology 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBD icon
26
CALL
Warner Bros
WBD
$65.9B
$15.1M 0.57%
+1,000,000
New +$14.2M
JBGS
27
JBG SMITH
JBGS
$818M
$15.1M 0.57%
1,000,000
-980,753
-50% -$17.4M
K
28
DELISTED
Kellanova
K
$9.93M 0.38%
+157,884
New +$9.97M
FHN icon
29
First Horizon
FHN
$12.2B
$8.72M 0.33%
+490,501
New +$10.9M
PYPL icon
30
PayPal
PYPL
$48.9B
$7.59M 0.29%
100,000
– –
NXT icon
31
Nextpower Inc
NXT
$13.6B
$6.35M 0.24%
+175,000
New +$5.54M
ROG icon
32
Rogers Corp
ROG
$2.21B
$5.74M 0.22%
35,123
– –
TNDM icon
33
Tandem Diabetes Care
TNDM
$1.34B
$4.95M 0.19%
+121,820
New +$5.04M
NML
34
Neuberger Energy Infrastructure and Income Fund Inc
NML
$583M
$3.4M 0.13%
+517,789
New +$3.58M
CTR
35
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$2.04M 0.08%
+70,692
New +$2.1M
MGNX icon
36
MacroGenics
MGNX
$235M
$1.76M 0.07%
244,864
– –
BHR
37
Braemar Hotels & Resorts
BHR
$156M
$100K ﹤0.01%
25,951
– –
APLS
38
DELISTED
Apellis Pharmaceuticals
APLS
– –
-149,000
Closed -$7.7M
ASND icon
39
Ascendis Pharma A/S
ASND
$16B
– –
-58,500
Closed -$7.14M
BLCO icon
40
Bausch + Lomb
BLCO
$6.04B
– –
-360,000
Closed -$5.58M
CLDX icon
41
Celldex Therapeutics
CLDX
$2.99B
– –
-212,000
Closed -$9.45M
LKFT
42
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.81B
– –
-46,583
Closed -$2.07M
META icon
43
Meta Platforms (Facebook)
META
$1.42T
– –
-400,000
Closed -$48.1M
NEOG icon
44
Neogen
NEOG
$2.63B
– –
-397,877
Closed -$6.06M
NWS icon
45
News Corp Class B
NWS
$16.9B
– –
-1,129,848
Closed -$20.8M
NWSA icon
46
News Corp Class A
NWSA
$14.9B
– –
-2,313,053
Closed -$42.1M
RLAY icon
47
Relay Therapeutics
RLAY
$4.1B
– –
-301,200
Closed -$4.5M
ZYME icon
48
Zymeworks
ZYME
$1.61B
– –
-740,878
Closed -$5.82M
1
2

Similar funds

PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
GVAG
Great Valley Advisor Group Wilmington, Delaware $5.5B AUM 20.56% 1-Year Est. Return
SWP
Sagespring Wealth Partners Franklin, Tennessee $5.49B AUM 19.47% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
DWA
Douglass Winthrop Advisors New York $5.46B AUM 11.49% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return

Sessa Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Sessa Capital held 49 positions worth $2.64B, up 62% from $1.63B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Sessa Capital deployed $751M of net new capital in Q1 2023, opening 17 new positions and adding to 3 existing holdings. Its largest new stake was First Citizens BancShares: 162,891 shares worth $159M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 17% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Provention Bio, Inc. Common Stock, an estimated $75.3M trimmed.

  • Sessa Capital's largest Q1 2023 buy was First Citizens BancShares: 162,891 shares worth $159M.
  • Sessa Capital added most to Ally Financial in Q1 2023, an estimated $220M increase.
  • Sessa Capital's biggest Q1 2023 reduction was Provention Bio, Inc. Common Stock, cutting an estimated $75.3M.
  • Sessa Capital fully exited Meta Platforms (Facebook) in Q1 2023, selling an estimated $48.1M.
  • Sessa Capital's ten largest holdings make up 71% of its $2.64B portfolio in Q1 2023.
  • Sessa Capital opened 17 new positions and closed 11 in Q1 2023.
  • Sessa Capital's portfolio value rose 62% quarter-over-quarter to $2.64B.

Based on Sessa Capital's 13F filing for Q1 2023, filed 15 May 2023.